Unusual 11 Mid-Day Movers 07/24: (SPRT) (HSTM) (SANM) Higher; (GNTX) (DV) (WBMD) Lower
Tweet Send to a Friend
Down)
Sarepta Therapeutics (Nasdaq: SRPT) 141.1% HIGHER; announced that treatment with its exon-skipping compound, eteplirsen, achieved a significant clinical benefit on the primary clinical outcome, the 6-minute walk test (6MWT), over a placebo/delayed treatment cohort in a Phase IIb trial in Duchenne muscular dystrophy (DMD) patients.
Gentex Corp (Nasdaq: GNTX) 28.4% LOWER; reported Q2 EPS of $0.28, $0.01 worse than the analyst estimate of $0.29. Revenue for the quarter came in at $280.3 million versus the consensus estimate of $280.55 million. As a result of the Kids Transportation Safety Act delays, and the uncertainties that they have created in the automotive market, the Company continues to believe that Rear Camera Display (RCD) Mirror unit shipments will be approximately flat for calendar year 2012 versus 2011.
DeVry, Inc. (NYSE: DV) 24.9% LOWER; sees Q4 EPS of $0.43-$0.46 vs $0.78 and revenues between $500 million and $510 million, versus the consensus of $516.7 million. The stock was downgraded at Citi, Topeka, JPMorgan and Oppenheimer.
WebMD Health Corp. (Nasdaq: WBMD) 22.0% LOWER; sees Q2 revs of $112 million and loss of 13 cents per share. The Street sees revs of $115.06 million and a loss of 10 cents per share. Now sees FY12 revs of $455 million to $480 million, from $500 - $535 million prior. Loss widens to $12.4 - $23.4 million, from net income of $2.8 - $19.9 million. The Street sees FY12 sales of $502.3 million.
HealthStream, Inc. (Nasdaq: HSTM) 16.6% HIGHER; reported Q2 EPS of $0.09, in-line with the analyst estimate of $0.09. Revenue for the quarter came in at $25.8 million versus the consensus estimate of $25.5 million. The Company published updated guidance and anticipates that consolidated revenues for the full year 2012 will grow by 22 to 25 percent when compared to the full year 2011.
Sanmina-SCI Corp (Nasdaq: SANM) 16.3% HIGHER; reported Q3 EPS of $0.26, $0.03 worse than the analyst estimate of $0.29. Revenue for the quarter came in at $1.55 billion versus the consensus estimate of $1.49 billion. Sees Q4 2012 EPS of $0.32-$0.38, versus the consensus of $0.34. Sees Q4 2012 revenue of $1.575-$1.625 billion, versus the consensus of $1.53 billion.
STR Holdings (NYSE: STRI) 15.9% LOWER; Craig-Hallum downgraded STR Holdings from Buy to Hold with a price target of $5.
Galectin Therapeutics (Nasdaq: GALT) 15.2% LOWER; pulling back Tuesday, following a strong 63.8 percent move higher Monday on the back of positive carbohydrate-based galectin inhibitor compound news.
Cynosure, Inc. (Nasdaq: CYNO) 12.6% HIGHER; reported Q2 EPS of $0.20, $0.10 better than the analyst estimate of $0.10. Revenue for the quarter came in at $39.6 million versus the consensus estimate of $35.95 million.
CoreLogic (NYSE: CLGX) 12.4% HIGHER; reported Q2 EPS of $0.46, $0.09 better than the analyst estimate of $0.37. Revenue for the quarter came in at $389.4 million versus the consensus estimate of $372.25 million.
KiOR (Nasdaq: KIOR) 12.6% HIGHER; higher after being granted Part 79 from the EPA for its Renewable Gasoline Blendstock 5.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Gentex Corp (Nasdaq: GNTX) 28.4% LOWER; reported Q2 EPS of $0.28, $0.01 worse than the analyst estimate of $0.29. Revenue for the quarter came in at $280.3 million versus the consensus estimate of $280.55 million. As a result of the Kids Transportation Safety Act delays, and the uncertainties that they have created in the automotive market, the Company continues to believe that Rear Camera Display (RCD) Mirror unit shipments will be approximately flat for calendar year 2012 versus 2011.
DeVry, Inc. (NYSE: DV) 24.9% LOWER; sees Q4 EPS of $0.43-$0.46 vs $0.78 and revenues between $500 million and $510 million, versus the consensus of $516.7 million. The stock was downgraded at Citi, Topeka, JPMorgan and Oppenheimer.
WebMD Health Corp. (Nasdaq: WBMD) 22.0% LOWER; sees Q2 revs of $112 million and loss of 13 cents per share. The Street sees revs of $115.06 million and a loss of 10 cents per share. Now sees FY12 revs of $455 million to $480 million, from $500 - $535 million prior. Loss widens to $12.4 - $23.4 million, from net income of $2.8 - $19.9 million. The Street sees FY12 sales of $502.3 million.
HealthStream, Inc. (Nasdaq: HSTM) 16.6% HIGHER; reported Q2 EPS of $0.09, in-line with the analyst estimate of $0.09. Revenue for the quarter came in at $25.8 million versus the consensus estimate of $25.5 million. The Company published updated guidance and anticipates that consolidated revenues for the full year 2012 will grow by 22 to 25 percent when compared to the full year 2011.
Sanmina-SCI Corp (Nasdaq: SANM) 16.3% HIGHER; reported Q3 EPS of $0.26, $0.03 worse than the analyst estimate of $0.29. Revenue for the quarter came in at $1.55 billion versus the consensus estimate of $1.49 billion. Sees Q4 2012 EPS of $0.32-$0.38, versus the consensus of $0.34. Sees Q4 2012 revenue of $1.575-$1.625 billion, versus the consensus of $1.53 billion.
STR Holdings (NYSE: STRI) 15.9% LOWER; Craig-Hallum downgraded STR Holdings from Buy to Hold with a price target of $5.
Galectin Therapeutics (Nasdaq: GALT) 15.2% LOWER; pulling back Tuesday, following a strong 63.8 percent move higher Monday on the back of positive carbohydrate-based galectin inhibitor compound news.
Cynosure, Inc. (Nasdaq: CYNO) 12.6% HIGHER; reported Q2 EPS of $0.20, $0.10 better than the analyst estimate of $0.10. Revenue for the quarter came in at $39.6 million versus the consensus estimate of $35.95 million.
CoreLogic (NYSE: CLGX) 12.4% HIGHER; reported Q2 EPS of $0.46, $0.09 better than the analyst estimate of $0.37. Revenue for the quarter came in at $389.4 million versus the consensus estimate of $372.25 million.
KiOR (Nasdaq: KIOR) 12.6% HIGHER; higher after being granted Part 79 from the EPA for its Renewable Gasoline Blendstock 5.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- J.P. Morgan (JPM) CEO Dimon Might Have Enough Votes to Stay Chairman - NY Times
- Trading Radar for 05/22: Salesforce.com (CRM), GameStop (GME), Heinz (HNZ), Gap (GPS),
- Streetinsider.com After-Hours Movers 05/21: (SKS) (NTAP) (LO) Higher; (UAN) (ADI) (BALT)
Create E-mail Alert Related Categories
Special ReportsRelated Entities
JPMorgan, Citi, Unusual 11 Mid-Day Movers
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
